Claspin may act as a tumor suppressor at the initial phases of malignant transformation, protecting the cell from oncogenic pressure, but it is possible that in the later stages of carcinogenesis, it may acquire oncogenic properties, fostering cancer progression and survival. This evidence concerns the gene CLSPN and neoplasm.